Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

A Menarini Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (40)
Cancellation by sponsor (14)
Australian public assessment report (AusPar) (5)
Prescription medicine registration (2)
Designation or determination (1)
Prescription medicine decision summary (1)

Date

2026 (3)
2025 (2)
2024 (1)
2023 (1)
2022 (3)
2021 (2)
2020 (3)
2019 (3)
2018 (5)
2017 (7)
2016 (8)
2015 (7)
2014 (3)
2013 (3)
2012 (1)
2010 (3)
2009 (4)
2006 (4)

Search

Sponsor content

63 result(s) found, displaying 21 to 30

RANEXA ranolazine 375mg modified release tablet blister pack (236110)

13 October 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RANEXA ranolazine 375mg modified release tablet blister pack.
RANEXA ranolazine 750mg modified release tablet blister pack (236108)

13 October 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RANEXA ranolazine 750mg modified release tablet blister pack.
PECFENT fentanyl (as fentanyl citrate) 100 microgram per actuation nasal spray solution with metered dose pump Section 30(1)(c) of the Act

21 April 2020

Cancellation by sponsor

Requested by A Menarini Australia Pty Ltd
PECFENT fentanyl (as fentanyl citrate) 400 microgram per actuation nasal spray solution with metered dose pump Section 30(1)(c) of the Act

21 April 2020

Cancellation by sponsor

Requested by A Menarini Australia Pty Ltd
VANIQA eflornithine hydrochloride 139mg/g cream tube Cancelled under Section 30(1)(c) of the Act

14 February 2020

Cancellation by sponsor

Requested by A Menarini Australia Pty Ltd
SANCUSO granisetron 3.1 mg/24 hours transdermal drug delivery system sachet Cancelled under Section 30(1)(c) of the Act

5 December 2019

Cancellation by sponsor

Requested by A Menarini Australia Pty Ltd
SPEDRA avanafil 50 mg tablet blister pack (228474)

6 April 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SPEDRA avanafil 50 mg tablet blister pack.
SPEDRA avanafil 200 mg tablet blister pack (228476)

6 April 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SPEDRA avanafil 200 mg tablet blister pack.
SPEDRA avanafil 100 mg tablet blister pack (228475)

6 April 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SPEDRA avanafil 100 mg tablet blister pack.
Seremind (259012)

3 September 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Seremind.

Pages

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.